Anavex Life Sciences Corp.
AVXL · NASDAQ
9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$46,377 | -$43,002 | -$47,505 | -$47,978 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $11,549 | $9,438 | $16,370 | $18,379 |
| Change in WC | $0 | $2,752 | $2,505 | $5,361 |
| Other Non-Cash | -$4,216 | $0 | $845 | $0 |
| Operating Cash Flow | -$39,044 | -$30,812 | -$27,785 | -$24,238 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $1,493 | $11,284 | $27,875 | $20,985 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $9,434 | $691 | $1,776 | $303 |
| Financing Cash Flow | $9,434 | $11,975 | $29,651 | $21,288 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$29,610 | -$18,837 | $1,866 | -$2,950 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $132,187 | $151,024 | $149,158 | $152,108 |
| End Cash | $102,577 | $132,187 | $151,024 | $149,158 |
| Free Cash Flow | -$39,044 | -$30,812 | -$27,785 | -$24,238 |